Article
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer.
Carcinogenesis - 1 Nov 2010
Wilhelm-Benartzi C S, Koestler D C, Houseman E A, Christensen B C, Wiencke John K, Schned A R, Karagas M R, Kelsey K T, Marsit C J
Abstract excerpt
DNA methylation profiles can be used to define molecular cancer subtypes that may better inform disease etiology and clinical decision-making. This investigation aimed to create DNA methylation profiles of bladder cancer based on CpG methylation from almost 800 cancer-related genes and to then examine the relationship of those profiles with exposures related to risk and clinical characteristics. DNA, derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
